Coxsackievirus-based Environmental Remediation Systems

Publication ID: 24-11857584_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Coxsackievirus-based Environmental Remediation Systems,” Published Technical Disclosure No. 24-11857584_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857584_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,584.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of oncolytic viruses to develop novel systems and methods for treating environmental pollutants, monitoring water quality, removing heavy metals, and breaking down industrial waste.

Background and Problem Solved

The original patent focused on the antitumor effects of coxsackievirus. However, the limitations of the original patent include its narrow application scope, failing to address the pressing environmental issues of pollution and waste management. The present inventive concept addresses these limitations by applying the core technology to an entirely different industry, field, or problem.

Detailed Description of the Inventive Concept

The inventive concept comprises systems and methods that utilize coxsackievirus and antimetabolites to degrade pollutants, detect pollutants in water, bind to heavy metals, and break down organic pollutants. The coxsackievirus is engineered to target specific pollutants, and the antimetabolite enhances the degradation, detection, or binding effects. These systems can be tailored to address various environmental pollutants, offering a versatile solution for environmental remediation.

Novelty and Inventive Step

The novelty of the present inventive concept lies in its application of oncolytic viruses to environmental remediation, which is entirely distinct from the original patent's antitumor focus. The inventive step involves the recognition of the potential of coxsackievirus and antimetabolites in addressing environmental pollution, and the development of novel systems and methods that achieve this goal.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different viruses, antimetabolites, or combinations thereof to target specific pollutants. Variations may also involve the development of portable systems for on-site remediation or the integration of these systems with existing waste management infrastructure.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the environmental remediation industry, with applications in pollution cleanup, water quality monitoring, and industrial waste management. The target market includes government agencies, private companies, and research institutions focused on environmental sustainability.

CPC Classifications

SectionClassGroup
A A61 A61K35/768
A A61 A61K31/282
A A61 A61K31/4745
A A61 A61K31/513
A A61 A61P35/00
C C12 C12N7/00
C C12 C12N2770/32332

Field of Art

Biotechnology and molecular virology, with expertise in oncolytic virus applications, pharmaceutical compositions, and environmental remediation techniques. Requires advanced degree (PhD/MD) with specialized knowledge in viral engineering, drug delivery, and biological systems interactions

Person of Ordinary Skill (PHOSITA) Profile

A skilled researcher with comprehensive understanding of viral mechanics, drug interactions, and cross-disciplinary applications of biological systems. Capable of recognizing potential technological extensions and analogous applications of established scientific principles

Obviousness Rationale

A PHOSITA would recognize the fundamental similarity between the source patent's oncolytic virus methodology and the PTD's environmental remediation approach. The core technological concept of using coxsackievirus with antimetabolites remains consistent, with the primary variation being the application domain. The systematic approach of virus-assisted targeting and enhancement through chemical co-administration represents a predictable technological extension.

Obvious Combinations & Variations

Source Patent Element
Method of administering coxsackievirus with oxaliplatin to enhance antitumor effects
PTD Variation
Administering coxsackievirus with antimetabolites to enhance pollutant degradation effects
Obviousness Reasoning
Known technique of using viral-chemical synergistic interactions, with predictable results across different application domains
Source Patent Element
Enhancing virus receptor expression using oxaliplatin
PTD Variation
Enhancing virus binding/detection capabilities in environmental pollutant scenarios
Obviousness Reasoning
Predictable extension of virus-chemical interaction principles to alternative targeting mechanisms
Source Patent Element
Targeting specific cellular mechanisms using coxsackievirus
PTD Variation
Targeting environmental pollutants through engineered viral systems
Obviousness Reasoning
Finite set of known viral engineering techniques applied to alternative problem-solving contexts
Source Patent Element
Combination therapy approach using virus and chemical agent
PTD Variation
Integrated systems for environmental remediation using virus-antimetabolite combinations
Obviousness Reasoning
Logical progression of established combination therapy principles to environmental technology domain
Source Patent Element
Method of promoting virus proliferation through chemical interaction
PTD Variation
Methods of enhancing virus performance in pollutant detection and degradation
Obviousness Reasoning
Predictable application of known viral performance enhancement techniques across different technological contexts
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857584, a Person Having Ordinary Skill In The Art would find the environmental remediation techniques disclosed herein to be an obvious variation of the established oncolytic virus methodologies. The systematic application of coxsackievirus and antimetabolite interactions to environmental challenges represents a predictable technological extension that lacks inventive complexity, thus rendering potential claims in this domain unpatentable as obvious variations of the prior art.

Original Patent Information

Patent NumberUS 11,857,584
TitleOncolytic virus growth method and antitumor agent
Assignee(s)KABUSHIKI KAISHA YAKULT HONSHA